Bank of America’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
28,542
+28,115
| +6,584% | +$252K | ﹤0.01% | 5121 |
|
|
2025
Q1 | $2.69K | Sell |
427
-626
| -59% | -$3.94K | ﹤0.01% | 6244 |
|
|
2024
Q4 | $10.8K | Buy |
1,053
+68
| +7% | +$701 | ﹤0.01% | 6050 |
|
|
2024
Q3 | $12.7K | Sell |
985
-744
| -43% | -$9.56K | ﹤0.01% | 5933 |
|
|
2024
Q2 | $23.9K | Sell |
1,729
-1,463
| -46% | -$20.2K | ﹤0.01% | 5826 |
|
|
2024
Q1 | $993K | Buy |
3,192
+298
| +10% | +$92.7K | ﹤0.01% | 4174 |
|
|
2023
Q4 | $758K | Buy |
2,894
+375
| +15% | +$98.2K | ﹤0.01% | 4336 |
|
|
2023
Q3 | $492K | Buy |
2,519
+263
| +12% | +$51.4K | ﹤0.01% | 4493 |
|
|
2023
Q2 | $464K | Buy |
2,256
+161
| +8% | +$33.1K | ﹤0.01% | 4530 |
|
|
2023
Q1 | $211K | Buy |
2,095
+60
| +3% | +$6.03K | ﹤0.01% | 5128 |
|
|
2022
Q4 | $320K | Buy |
2,035
+142
| +8% | +$22.3K | ﹤0.01% | 4947 |
|
|
2022
Q3 | $474K | Sell |
1,893
-57
| -3% | -$14.3K | ﹤0.01% | 4708 |
|
|
2022
Q2 | $551K | Buy |
1,950
+306
| +19% | +$86.5K | ﹤0.01% | 4686 |
|
|
2022
Q1 | $330K | Sell |
1,644
-33
| -2% | -$6.62K | ﹤0.01% | 5381 |
|
|
2021
Q4 | $366K | Sell |
1,677
-533
| -24% | -$116K | ﹤0.01% | 5332 |
|
|
2021
Q3 | $1.01M | Buy |
2,210
+1,590
| +256% | +$725K | ﹤0.01% | 4335 |
|
|
2021
Q2 | $249K | Sell |
620
-27
| -4% | -$10.8K | ﹤0.01% | 5188 |
|
|
2021
Q1 | $374K | Buy |
647
+214
| +49% | +$124K | ﹤0.01% | 4970 |
|
|
2020
Q4 | $246K | Buy |
433
+55
| +15% | +$31.2K | ﹤0.01% | 4763 |
|
|
2020
Q3 | $212K | Sell |
378
-1,842
| -83% | -$1.03M | ﹤0.01% | 4669 |
|
|
2020
Q2 | $1.26M | Buy |
+2,220
| New | +$1.26M | ﹤0.01% | 3527 |
|